🇨🇦 Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf in Canada

Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) regulatory status in Canada.

Marketing authorisation

Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf in Canada?

Genentech, Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.